UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk

Journal of experimental & clinical cancer research, 2023-07, Vol.42 (1), p.173-173, Article 173

2023

Volltextzugriff (PDF)

Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology

Experimental and Molecular Medicine, 2024, 56(0), , pp.1531-1551

2024

Volltextzugriff (PDF)

Potential of PSMA for breast cancer in nuclear medicine: digital quantitative immunohistochemical analysis and implications for a theranostic approach

BMC cancer, 2024-10, Vol.24 (1), p.1328-5, Article 1328

2024

Volltextzugriff (PDF)

Tumor Suppressive Role of miR-342-5p in Human Chondrosarcoma Cells and 3D Organoids

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5590

2021

Volltextzugriff (PDF)

Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)

BMC cancer, 2022-05, Vol.22 (1), p.537-537, Article 537

2022

Volltextzugriff (PDF)

Control of cell death/survival balance by the MET dependence receptor

eLife, 2020-02, Vol.9

2020

Volltextzugriff (PDF)

Effect of 2-Deoxy-D-glucose on Various Malignant Cell Lines In Vitro

Anticancer research, 2006-09, Vol.26 (5A), p.3561-3566

2006

Volltextzugriff (PDF)

Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells

Molecular cancer therapeutics, 2009-11, Vol.8 (11), p.3162-3170

2009

Volltextzugriff (PDF)

Effect of Citrate on Malignant Pleural Mesothelioma Cells: A Synergistic Effect with Cisplatin

Anticancer research, 2009-04, Vol.29 (4), p.1249-1254

2009

Volltextzugriff (PDF)

Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route

Oncology reports, 2017-10, Vol.38 (4), p.1949-1958

2017

Volltextzugriff (PDF)

Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies

Journal of bioenergetics and biomembranes, 2012-02, Vol.44 (1), p.81-90

2012

Volltextzugriff (PDF)

Novel Therapy for Malignant Pleural Mesothelioma Based on Anti-energetic Effect: An Experimental Study Using 3-Bromopyruvate on Nude Mice

Anticancer research, 2009-04, Vol.29 (4), p.1443-1448

2009

Volltextzugriff (PDF)

Vitronectin and Its Receptors Partly Mediate Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium in vitro

Tumor biology, 2008-01, Vol.29 (4), p.231-244

2008

Volltextzugriff (PDF)

Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database

The Lancet. Haematology, 2021-02, Vol.8 (2), p.e122-e134

2021

Volltextzugriff (PDF)

Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays

British journal of cancer, 2021-07, Vol.125 (1), p.7-14

2021

Volltextzugriff (PDF)

PSMA Expression in Differentiated Thyroid Cancer: Association With Radioiodine, 18FDG Uptake, and Patient Outcome

The journal of clinical endocrinology and metabolism, 2021-11, Vol.106 (12), p.3536-3545

2021

Volltextzugriff (PDF)

An overview of long non-coding RNAs in ovarian cancers

Oncotarget, 2016-07, Vol.7 (28), p.44719-44734

2016

Volltextzugriff (PDF)

Drug Repositioning of the α 1 -Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?

International journal of molecular sciences, 2020-07, Vol.21 (15)

2020

Volltextzugriff (PDF)

Citrate induces apoptotic cell death: a promising way to treat gastric carcinoma?

Anticancer research, 2011-03, Vol.31 (3), p.797-805

2011

Volltextzugriff (PDF)

The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737

Molecular cancer therapeutics, 2017-01, Vol.16 (1), p.102-115

2017

Volltextzugriff (PDF)

Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib

Cell death & disease, 2020-05, Vol.11 (5), p.380, Article 380

2020

Volltextzugriff (PDF)

Updates and current challenges in microRNA research for personalized medicine in ovarian cancer

Expert opinion on biological therapy, 2017-08, Vol.17 (8), p.927-943

2017

Volltextzugriff (PDF)

Bcl‐XL and MCL‐1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis

International journal of cancer, 2010-02, Vol.126 (4), p.885-895

2010

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(81)

Sprache

Englisch
(73)
Französisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(61)
Female
(45)
Life Sciences
(28)
Oncology
(27)
Male
(22)
Cell Line, Tumor
(21)
Cancer
(20)
Adult
(19)
Ovarian Cancer
(17)
Animals
(16)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Middle Aged
(15)
Tumors
(14)
Apoptosis
(13)
Aged
(11)
Antineoplastic Agents - Pharmacology
(11)
Cisplatin - Pharmacology
(11)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk

Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology

Potential of PSMA for breast cancer in nuclear medicine: digital quantitative immunohistochemical analysis and implications for a theranostic approach

Tumor Suppressive Role of miR-342-5p in Human Chondrosarcoma Cells and 3D Organoids

The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers

Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)

ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies

Control of cell death/survival balance by the MET dependence receptor

Effect of 2-Deoxy-D-glucose on Various Malignant Cell Lines In Vitro

Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells

Effect of Citrate on Malignant Pleural Mesothelioma Cells: A Synergistic Effect with Cisplatin

Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route

Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies

Novel Therapy for Malignant Pleural Mesothelioma Based on Anti-energetic Effect: An Experimental Study Using 3-Bromopyruvate on Nude Mice

Vitronectin and Its Receptors Partly Mediate Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium in vitro

Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database

Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays

PSMA Expression in Differentiated Thyroid Cancer: Association With Radioiodine, 18FDG Uptake, and Patient Outcome

An overview of long non-coding RNAs in ovarian cancers

Drug Repositioning of the α 1 -Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?

Citrate induces apoptotic cell death: a promising way to treat gastric carcinoma?

The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737

Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib

Updates and current challenges in microRNA research for personalized medicine in ovarian cancer

Bcl‐XL and MCL‐1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis

Aktive Filter

Suchergebnisse filtern